Get the Stockscreener App
16.10
3.94%
-0.66
Vogenx Inc Common Stock stock is traded at $16.10, with a volume of 94,222.
It is down -3.94% in the last 24 hours and down -50.02% over the past month.
See More
Previous Close:
$16.76
Open:
$16.97
24h Volume:
94,222
Relative Volume:
0.96
Market Cap:
$239.17M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-7.95%
1M Performance:
-50.02%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$15.25
$19.17
52-Week Range:
$12.95
$38.41
Vogenx Inc Common Stock Stock (VOGX) Company Profile
Name
Vogenx Inc Common Stock
Sector
Industry
Phone
-
Address
-
Compare VOGX vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VOGX
Vogenx Inc Common Stock
|
16.10 | 239.17M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
239.46 | 95.60B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
798.85 | 82.25B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
852.08 | 53.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.16 | 42.33B | 5.76B | 514.49M | 1.10B | 4.4813 |
Vogenx Inc Common Stock Stock (VOGX) Latest News
Vogenx Director Peter Pieraccini Granted 50,000 Stock Options at $18.23 Exercise Price - Kalkine Media
155,000 options for Vogenx (VOGX) science chief vest over three years, subject to continued service. - Stock Titan
A director receives 50,000 Vogenx (VOGX) stock options with an $18.23 exercise price. - Stock Titan
Options priced at $18.23 go to Vogenx (VOGX) CFO Steven R. Delmar in a 155,000-option grant. - Stock Titan
Vogenx Director Kenneth John Toombs Submits Initial Form 3 Reporting No Securities Ownership - Kalkine Media
IPO cash gives Vogenx (VOGX) runway amid losses and control weaknesses - Stock Titan
One asset manager group now reports 13% of Vogenx (VOGX) - Stock Titan
Vogenx (VOGX) insiders report 700,000-share stake in new filing - Stock Titan
Vogenx (NASDAQ: VOGX) CFO holds 700K shares plus options - Stock Titan
Vogenx (VOGX) CEO details 1.8M-share stake and option grants - Stock Titan
Vogenx (VOGX) CSO reports options plus 1.8M indirect shares - Stock Titan
Vogenx (VOGX) director holds stock options out to 2036 - Stock Titan
Vogenx (VOGX) director details $0.93–$1.20 stock options - Stock Titan
Vogenx Strengthens Capital Base With IPO Over-Allotment - TipRanks
Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering - PR Newswire
Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering - Nasdaq
Vogenx Announces Closing of Initial Public Offering - Yahoo Finance
Vogenx closes $81.3M IPO at $13 per share, lists on Nasdaq - scanx.trade
Vogenx, Clinical-Stage Biopharmaceutical Developer, Files for NASDAQ IPO - TradingView
Vogenx, Inc. (VOGX) Stock Price, News, Quote & History - Yahoo Finance
Vogenx (VOGX) director reports 26,665 options, 42,735-share note - Stock Titan
VOGX SEC Filings, Aug 12, 2026Vogenx, Inc. Filing Archive - Stock Titan
Vogenx Announces Pricing of Initial Public Offering - Yahoo Finance
Funding Roundup: Braveheart, Attovia, Vogenx All Announce IPO’s - Pharmaceutical Executive
Vogenx, Clinical-Stage Metabolic Disease Therapeutics, Files for Nasdaq Capital Market IPO - TradingView
Vogenx Announces Initial Public Offering Of Common StockSEC Filing - TradingView
Vogenx Inc Common Stock Stock (VOGX) Financials Data
There is no financial data for Vogenx Inc Common Stock (VOGX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):